Amneal Pharmaceuticals, Inc.
$AMRX
Public valuation for Amneal Pharmaceuticals, Inc. (AMRX). Fair value, signal, and key metrics — no sign-in required.
Current Price
$20.14
Fairly Valued
Fair Value Estimate
$21
🏛️
Mature Growth
Profitable company with steady growth
Analyst Consensus
Target: $22.71
13% higher than current
Key Metrics
Market Cap
$7.0B
Forward P/E
21.7x
Operating Margin
16.3%
Revenue Growth
8.5%
PEG Ratio
1.98
Get free watchlist alerts
Join the waitlist for valuation updates on $AMRX and the rest of your watchlist.
Join the waitlistJoin the waitlist
Stay on this page to join — no sign-in required.